Topic
Drug Labeling
96 published works
Drug & Device Law
New Jersey Accutane Plaintiff Verdict Vacated – Appellate Division Strongly Criticizes Evidentiary Rulings
If you read the decision in Rossitto v. Hoffmann-LaRoche Inc., 2016 N.J. Super. Unpub. LEXIS 1714 (N.J. App. Div. Jul 22, 2016), we think you’ll agree with our calling it…
Drug & Device Law
Stick a Fork in It – FDA Anti-Generic Drug Preemption Proposal Postponed Until After the Presidential Election
By Bexis
On May 18, the FDA extended the comment period for its proposed generic drug labeling rule until April 2017 – that is, until after the next presidential election. We believe…
Drug & Device Law
Breaking News – FDA Generic Drug Anti-Preemption Proposal Again Deferred
By Bexis
We just read on 360 this morning that the FDA has again postponed its schedule for finalizing the generic drug labeling changes (the so-called "Supplemental Applications Proposing Labeling Changes for…
Drug & Device Law
Incretin Preemption Part II – California Tosses Failure to Warn Claims Too
This post is from the non-Reed Smith side of the blog. Last week we posted about the decision in In re Incretin-Based Therapies Products Liability Litigation (S.D. Cal.) dismissing plaintiffs’ failure to warn…
Food Safety News
DOJ Seeks Criminal Contempt Sanctions Against MT Supplements Seller
By News Desk
On one of his websites, Toby McAdam, 57, is letting prospective customers know that he cannot sell his dietary supplements until he works out a labeling issue with the U.S.…
The Brand Protection Blog
Canadian plain language labelling requirements take effect for drug products
The Regulations Amending the Food and Drug Regulations (Labelling, Packaging and Brand Names of Drugs for Human Use) - more commonly known as the “Plain Language Labelling amendments” - as…
Product Liability & Mass Torts Blog
FDA Reopens Comment Period for Drug Labeling Rule
By Matthew J. Fischer, Jamie Lynn Lanphear
The consequences of the Supreme Court’s decision in Pliva v. Mensing continue to play out on multiple tracks. Most recently, the FDA has reopened the comment period for its proposed…
Drug & Device Law
Breaking News – First Circuit Extends Mensing Preemption To Innovator Drugs
By Bexis
We’ve argued since PLIVA v. Mensing, 131 S. Ct. 2567 (2011), was first decided that its impossibility preemption rationale extended to innovator/branded drugs and was not limited to generics. We’ve…
Health Care and Life Sciences
The Rise of the Online Package Insert?
On December 18, 2014, FDA released proposed regulations that would make prescribing information for drugs and biologics available online and prohibit distribution of paper copies as part of product packaging. …
Life Sciences Legal Update
FDA Announces Plan to Encourage Voluntary Updating of Drug and Biologics Labels
By Lisa Baird
As mentioned on our Health Industry Washington Watch blog, the U.S. Food and Drug Administration (FDA) has announced a plan intended to incentivize manufacturers to voluntarily update their prescription drug…